Lanreotide Acetate Injectable Drug Recalled Nationwide for Particulate Matter Contamination
Cipla USA is recalling 15,221 pre-filled syringes of Lanreotide Acetate 120 mg/0.5 mL due to the presence of particulate matter. The prescription injectable was distributed nationwide and patients should contact their healthcare provider.
- Product
- LANREOTIDE ACETATE — LANREOTIDE ACETATE (LANREOTIDE ACETATE)
- Category
- Drug
- Distribution
- Distributed nationwide